Bespoke Extracts Q1 net loss narrows to $260.5K; rebrands as The Joint Company, guides Q2 revenue above $385K

Bespoke Extracts, Inc.

2025-Q2 EPS reported -$0.04 revenue$653,712

Revenue $263,159 (+1.0% YoY); gross profit $110,779; net loss $260,521 vs $314,118; EPS -$0.02 vs -$0.03.
Rebranded as The Joint Company; launched Doobskis and Dutch Blunts; pre-roll production up 32% YoY.
Q2 2025 revenue guidance exceeding $385,000 vs $278,163 in Q2 2024.
Operating expenses fell to $356,117 from $405,384; cost efficiencies improved gross margin.
Cash $30,365; total liabilities $2.58M; stockholders' deficit $2.33M; negative equity persists.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.